Zobrazeno 1 - 10
of 141
pro vyhledávání: '"Erik H, Serné"'
Autor:
Jessica C.G. Bak, Erik H. Serné, Rolf H.H. Groenwold, Harold W. de Valk, Mark H.H. Kramer, Max Nieuwdorp, Carianne L. Verheugt
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 15, Iss 1, Pp 1-11 (2023)
Abstract Aims The COVID-19 pandemic impacted diabetes care by reducing diabetes outpatient visits and diabetes-related screening due to allocation of healthcare resources. Yet the impact of COVID-19 on diabetes outpatients has not been extensively ev
Externí odkaz:
https://doaj.org/article/0745385d6f2d49b8afaaf56affabd4be
Autor:
Marlinde L. van Dijk, Leonie M. te Loo, Joyce Vrijsen, Inge van den Akker-Scheek, Sanne Westerveld, Marjan Annema, André van Beek, Jip van den Berg, Alexander L. Boerboom, Adrie Bouma, Martine de Bruijne, Jeroen Crasborn, Johanna M. van Dongen, Anouk Driessen, Karin Eijkelenkamp, Nies Goelema, Jasmijn Holla, Johan de Jong, Anoek de Joode, Arthur Kievit, Josine van’t Klooster, Hinke Kruizenga, Marike van der Leeden, Lilian Linders, Jenny Marks-Vieveen, Douwe Johannes Mulder, Femmy Muller, Femke van Nassau, Joske Nauta, Suzanne Oostvogels, Jessica Oude Sogtoen, Hidde P. van der Ploeg, Patrick Rijnbeek, Linda Schouten, Rhoda Schuling, Erik H. Serné, Simone Smuling, Maarten R. Soeters, Evert A. L. M. Verhagen, Johannes Zwerver, Rienk Dekker, Willem van Mechelen, Judith G. M. Jelsma
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-21 (2023)
Abstract Background A healthy lifestyle is indispensable for the prevention of noncommunicable diseases. However, lifestyle medicine is hampered by time constraints and competing priorities of treating physicians. A dedicated lifestyle front office (
Externí odkaz:
https://doaj.org/article/b59b2025dcfb4fe5a2cab6059ca5005b
Autor:
Frank J Snoek, Karel G M Moons, Mirjam M Oosterwerff, Thomas van Bemmel, Catherine B Brouwer, Arianne C van Bon, Harold W de Valk, J Hans deVries, Lioe-Ting Dijkhorst-Oei, Peter R van Dijk, Klaas Hoogenberg, Sarah E Siegelaar, Titia M Vriesendorp, Erik H Serné, Geert W J Frederix, Milena Jancev, Heleen Knottnerus, Helga Blauw, Maureen Witkop, Thomas T van Sloten, Frits A W Kemperman, Lars P Klieverik, Elin Seebus
Publikováno v:
BMJ Open, Vol 13, Iss 8 (2023)
Introduction The management of type 1 diabetes (T1DM) has undergone significant advancements with the availability of novel technologies, notably continuous and flash glucose monitoring (CGM and FGM, respectively) and hybrid closed loop (HCL) therapy
Externí odkaz:
https://doaj.org/article/dd5f612a68824e97a555e2b0371f2a8f
Autor:
Charlotte C. van Ruiten, Mark M. Smits, Megan D. Kok, Erik H. Serné, Daniël H. van Raalte, Mark H. H. Kramer, Max Nieuwdorp, Richard G. IJzerman
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-12 (2022)
Abstract Background Sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) lower blood pressure (BP). When SGLT2i and GLP-1RA are combined, synergistic effects on BP have been observed. The mechanis
Externí odkaz:
https://doaj.org/article/2f213ea61ef843a7a51f21a2f65b1f70
Autor:
Jessica C. G. Bak, Dick Mul, Erik H. Serné, Harold W. de Valk, Theo C. J. Sas, Petronella H. Geelhoed-Duijvestijn, Mark H. H. Kramer, Max Nieuwdorp, Carianne L. Verheugt
Publikováno v:
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Treatment of diabetes mellitus has majorly improved over the past century, however, the disease burden is high and its prevalence still expanding. Further insight in the diabetes population is imperative to improve the quality of
Externí odkaz:
https://doaj.org/article/13adcf85922249a9beb0ee2093fbbe5b
Autor:
Alexander V. van Schoonhoven, Marcel H. Schöttler, Erik H. Serné, Patrick P.G Schrömbges, Maarten J. Postma, Cornelis Boersma
Publikováno v:
van Schoonhoven, A V, Schöttler, M H, Serné, E H, Schrömbges, P P G, Postma, M J & Boersma, C 2023, ' The health and budget impact of sodium-glucose co-transporter-2 inhibitors (SGLT2is) in The Netherlands ', Journal of Medical Economics, vol. 26, no. 1, pp. 547-553 . https://doi.org/10.1080/13696998.2023.2194802
Journal of Medical Economics, 26(1), 547-553. Taylor and Francis Ltd.
Journal of Medical Economics, 26(1), 547-553. Taylor and Francis Ltd.
Objectives: Type-2 Diabetes mellitus (T2DM) increases both the patient risk of cardiovascular disease (CVD) and renal outcomes, such as chronic kidney disease (CKD). Recent clinical trials of the glucose-lowering drug-class of sodium-glucose co-trans
Autor:
Christa C. van Bunderen, Rick I. Meijer, Paul Lips, Mark H. Kramer, Erik H. Serné, Madeleine L. Drent
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2021)
To clarify the mechanism underlying the described U-shaped relation of both low and high levels of IGF-1 with cardiovascular disease this study explores the effect of decreasing and increasing growth hormone dose in GH deficient adults on (micro)vasc
Externí odkaz:
https://doaj.org/article/b4311bca9db540a08e0a32a6bac5a633
Autor:
Linda T. Muijs, Caterina Racca, Maartje deWit, Annelies Brouwer, Thomas H. Wieringa, Ralph deVries, Erik H. Serné, Daniël H. vanRaalte, Femke Rutters, Frank J. Snoek
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 4, Iss 1, Pp n/a-n/a (2021)
Abstract Aims To systematically review the literature regarding the association between glucose variability (GV) and mood in adults with diabetes, appraise the used methods and make suggestions for future research. Methods A systematic review of lite
Externí odkaz:
https://doaj.org/article/db0f2bc42863447caee16f7251c6d19b
Autor:
Elles Konijnenberg, Stephen F. Carter, Mara ten Kate, Anouk den Braber, Jori Tomassen, Chinenye Amadi, Linda Wesselman, Hoang-Ton Nguyen, Jacoba A. van de Kreeke, Maqsood Yaqub, Matteo Demuru, Sandra D. Mulder, Arjan Hillebrand, Femke H. Bouwman, Charlotte E. Teunissen, Erik H. Serné, Annette C. Moll, Frank D. Verbraak, Rainer Hinz, Neil Pendleton, Adriaan A. Lammertsma, Bart N. M. van Berckel, Frederik Barkhof, Dorret I. Boomsma, Philip Scheltens, Karl Herholz, Pieter Jelle Visser
Publikováno v:
Alzheimer’s Research & Therapy, Vol 10, Iss 1, Pp 1-12 (2018)
Abstract Background Amyloid pathology is the pathological hallmark in Alzheimer’s disease (AD) and can precede clinical dementia by decades. So far it remains unclear how amyloid pathology leads to cognitive impairment and dementia. To design AD pr
Externí odkaz:
https://doaj.org/article/1550fd3ad24a4070bf47c772e48b117e
Autor:
Silvia A. G. de Vries, Jessica C. G. Bak, Erik H. Serné, Mark H. H. Kramer, Carianne L. Verheugt
Publikováno v:
Nederlands Tijdschrift voor Diabetologie. 21:13-15